High TRGV 9 Subfamily Expression Marks an Improved Overall Survival in Patients With Acute Myeloid Leukemia.
Saved in:
| Title: | High TRGV 9 Subfamily Expression Marks an Improved Overall Survival in Patients With Acute Myeloid Leukemia. |
|---|---|
| Authors: | Kong X; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China., Zheng J; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China., Liu X; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China., Wang W; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China., Jiang X; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China., Chen J; Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou, China., Lai J; Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou, China., Jin Z; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.; Department of Pathology, School of Medicine, Jinan University, Guangzhou, China., Wu X; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China. |
| Source: | Frontiers in immunology [Front Immunol] 2022 Feb 10; Vol. 13, pp. 823352. Date of Electronic Publication: 2022 Feb 10 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2022.823352 |
